Health Language Blog

Central Cancer Registries: Ensuring the EHR Meets MU2 Requirements

Posted on 07/29/13


The ability of public health organizations to efficiently track and monitor cancer cases via registries is critical to the national effort to reduce morbidity and mortality rates. That’s why, in 1992, Congress mandated that individual states establish central cancer registries (CCRs) to capture diagnostic, treatment and outcomes data for every cancer patient living in the U.S.

Hospitals have long submitted data to these registries, but today a growing number of cancer patients receive treatment outside of hospitals in ambulatory healthcare settings. As a result, Meaningful Use (MU) Stage 2 includes an objective that requires providers in ambulatory settings to identify and report cancer cases to state registries. The MU Stage 2 measure requires healthcare providers to consistently and successfully submit cancer data through a certified EHR to their state’s cancer registries for the entire EHR reporting period.

To attest to MU Stage 2 criteria for cancer registry reporting, the CDC’s Implementation Guide for Healthcare Provider Reporting to Central Cancer Registries recommends that a provider’s EHR be capable of:

  • Identifying reportable cancer cases;
  • Identifying the specific data elements to be retrieved and included in the cancer event report;
  • Creating a valid HL7 CDA R2 cancer event report; and
  • Transmitting the cancer event report securely to a CCR electronically

EHRs can greatly streamline cancer data collection processes for providers by automating the identification and submission of reportable cases to state registries. The use of interoperable EHR technology based on standardized terminologies, such as HL7, LOINC and SNOMED, is essential to ensuring the seamless transmission of data between healthcare providers and their state’s cancer registry as required by MU Stage 2.

*Background information for this post was sourced from the “Implementation Guide for Healthcare Provider Reporting to Central Cancer Registries” developed by the Centers for Disease Control and Prevention.

White Paper: Meet the Challenges of Meaningful Use Stage 2

Topics: Meaningful use, Meaningful Use (MU) Stage 2, MU Stage 2, EHR Technology, LOINC & SNOMED, Cancer Registries, EHR, MU2 requirements

About the Author

Soraya Assar